nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—Carboplatin—testicular cancer	0.239	0.313	CbGbCtD
Aminosalicylic Acid—MPO—Cisplatin—testicular cancer	0.204	0.267	CbGbCtD
Aminosalicylic Acid—PTGS1—Ifosfamide—testicular cancer	0.122	0.16	CbGbCtD
Aminosalicylic Acid—PTGS2—Cisplatin—testicular cancer	0.0705	0.0923	CbGbCtD
Aminosalicylic Acid—PTGS2—Etoposide—testicular cancer	0.0693	0.0907	CbGbCtD
Aminosalicylic Acid—PTGS1—Etoposide—testicular cancer	0.0585	0.0766	CbGbCtD
Aminosalicylic Acid—CHUK—Validated transcriptional targets of TAp63 isoforms—TFAP2C—testicular cancer	0.00481	0.0584	CbGpPWpGaD
Aminosalicylic Acid—CHUK—FCERI mediated NF-kB activation—BCL10—testicular cancer	0.00353	0.0428	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—BCL10—testicular cancer	0.00353	0.0428	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00351	0.0426	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00292	0.0355	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00279	0.0338	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream TCR signaling—BCL10—testicular cancer	0.00222	0.027	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—MAD1L1—testicular cancer	0.00214	0.026	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—BCL10—testicular cancer	0.00181	0.0219	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling—BCL10—testicular cancer	0.00166	0.0201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activation of NF-kappaB in B cells—BCL10—testicular cancer	0.00154	0.0186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—BCL10—testicular cancer	0.00152	0.0184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—BCL10—testicular cancer	0.0015	0.0182	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—H2AFZ—testicular cancer	0.00149	0.0181	CbGpPWpGaD
Aminosalicylic Acid—Pericarditis—Epirubicin—testicular cancer	0.0014	0.00913	CcSEcCtD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—KITLG—testicular cancer	0.00138	0.0167	CbGpPWpGaD
Aminosalicylic Acid—Pericarditis—Doxorubicin—testicular cancer	0.0013	0.00845	CcSEcCtD
Aminosalicylic Acid—PTGS1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00127	0.0154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—BCL10—testicular cancer	0.00118	0.0144	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Chlorambucil—testicular cancer	0.00114	0.0074	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Carboplatin—testicular cancer	0.00114	0.0074	CcSEcCtD
Aminosalicylic Acid—Jaundice—Chlorambucil—testicular cancer	0.00113	0.00735	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—BCL10—testicular cancer	0.00111	0.0135	CbGpPWpGaD
Aminosalicylic Acid—Haemolytic anaemia—Ifosfamide—testicular cancer	0.0011	0.00717	CcSEcCtD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.00108	0.0131	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00107	0.0129	CbGpPWpGaD
Aminosalicylic Acid—Eruption—Methotrexate—testicular cancer	0.00105	0.00686	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Vinblastine—testicular cancer	0.00104	0.00678	CcSEcCtD
Aminosalicylic Acid—CHUK—Osteopontin-mediated events—MMP2—testicular cancer	0.00101	0.0123	CbGpPWpGaD
Aminosalicylic Acid—Encephalopathy—Methotrexate—testicular cancer	0.00101	0.00657	CcSEcCtD
Aminosalicylic Acid—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00101	0.0122	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Ifosfamide—testicular cancer	0.000996	0.00648	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Vinblastine—testicular cancer	0.000992	0.00645	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Epirubicin—testicular cancer	0.000987	0.00642	CcSEcCtD
Aminosalicylic Acid—Eruption—Epirubicin—testicular cancer	0.000987	0.00642	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Cisplatin—testicular cancer	0.000951	0.00618	CcSEcCtD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—KIT—testicular cancer	0.000938	0.0114	CbGpPWpGaD
Aminosalicylic Acid—Eruption—Doxorubicin—testicular cancer	0.000913	0.00594	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Doxorubicin—testicular cancer	0.000913	0.00594	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Bleomycin—testicular cancer	0.000911	0.00593	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.000858	0.00558	CcSEcCtD
Aminosalicylic Acid—Anaemia—Chlorambucil—testicular cancer	0.000838	0.00545	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Epirubicin—testicular cancer	0.00082	0.00534	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Chlorambucil—testicular cancer	0.000811	0.00528	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Dactinomycin—testicular cancer	0.000781	0.00508	CcSEcCtD
Aminosalicylic Acid—Anaemia—Vinblastine—testicular cancer	0.000768	0.00499	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Doxorubicin—testicular cancer	0.000759	0.00494	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Ifosfamide—testicular cancer	0.000752	0.00489	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Dactinomycin—testicular cancer	0.000752	0.00489	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Vinblastine—testicular cancer	0.000744	0.00484	CcSEcCtD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KITLG—testicular cancer	0.00074	0.00899	CbGpPWpGaD
Aminosalicylic Acid—Thrombocytopenia—Chlorambucil—testicular cancer	0.000724	0.00471	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—BCL10—testicular cancer	0.000722	0.00876	CbGpPWpGaD
Aminosalicylic Acid—Agranulocytosis—Ifosfamide—testicular cancer	0.000716	0.00466	CcSEcCtD
Aminosalicylic Acid—Anorexia—Chlorambucil—testicular cancer	0.000705	0.00459	CcSEcCtD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000697	0.00846	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000689	0.00836	CbGpPWpGaD
Aminosalicylic Acid—Hepatitis—Ifosfamide—testicular cancer	0.000689	0.00448	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Ifosfamide—testicular cancer	0.00068	0.00442	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Ifosfamide—testicular cancer	0.000675	0.00439	CcSEcCtD
Aminosalicylic Acid—CHUK—PI-3K cascade—KITLG—testicular cancer	0.000667	0.00809	CbGpPWpGaD
Aminosalicylic Acid—Vasculitis—Methotrexate—testicular cancer	0.000665	0.00432	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Vinblastine—testicular cancer	0.000664	0.00432	CcSEcCtD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—KITLG—testicular cancer	0.000651	0.0079	CbGpPWpGaD
Aminosalicylic Acid—Anaemia—Bleomycin—testicular cancer	0.000648	0.00422	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Cisplatin—testicular cancer	0.000648	0.00422	CcSEcCtD
Aminosalicylic Acid—Anorexia—Vinblastine—testicular cancer	0.000646	0.0042	CcSEcCtD
Aminosalicylic Acid—CHUK—GAB1 signalosome—KITLG—testicular cancer	0.000646	0.00784	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Chlorambucil—testicular cancer	0.000643	0.00418	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000639	0.00415	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Activation—BCL10—testicular cancer	0.000638	0.00774	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KITLG—testicular cancer	0.000631	0.00766	CbGpPWpGaD
Aminosalicylic Acid—Leukopenia—Bleomycin—testicular cancer	0.000628	0.00408	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000605	0.00393	CcSEcCtD
Aminosalicylic Acid—Anaemia—Dactinomycin—testicular cancer	0.000605	0.00393	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Ifosfamide—testicular cancer	0.0006	0.0039	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Etoposide—testicular cancer	0.000594	0.00386	CcSEcCtD
Aminosalicylic Acid—Jaundice—Etoposide—testicular cancer	0.000591	0.00384	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Vinblastine—testicular cancer	0.000589	0.00383	CcSEcCtD
Aminosalicylic Acid—Urticaria—Chlorambucil—testicular cancer	0.000588	0.00382	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Cisplatin—testicular cancer	0.000586	0.00381	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Dactinomycin—testicular cancer	0.000586	0.00381	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Chlorambucil—testicular cancer	0.000585	0.0038	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Chlorambucil—testicular cancer	0.000585	0.0038	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Cisplatin—testicular cancer	0.000582	0.00379	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000582	0.00706	CbGpPWpGaD
Aminosalicylic Acid—Agranulocytosis—Etoposide—testicular cancer	0.000566	0.00368	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Bleomycin—testicular cancer	0.000561	0.00365	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Vinblastine—testicular cancer	0.000554	0.00361	CcSEcCtD
Aminosalicylic Acid—Anaemia—Ifosfamide—testicular cancer	0.000554	0.0036	CcSEcCtD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—MMP2—testicular cancer	0.000553	0.00671	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—testicular cancer	0.00055	0.00668	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Bleomycin—testicular cancer	0.000546	0.00355	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Chlorambucil—testicular cancer	0.000545	0.00355	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Etoposide—testicular cancer	0.000537	0.00349	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Ifosfamide—testicular cancer	0.000537	0.00349	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vinblastine—testicular cancer	0.000536	0.00349	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Etoposide—testicular cancer	0.000533	0.00347	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dactinomycin—testicular cancer	0.000523	0.0034	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Cisplatin—testicular cancer	0.000517	0.00336	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.00051	0.00619	CbGpPWpGaD
Aminosalicylic Acid—Flatulence—Cisplatin—testicular cancer	0.000509	0.00331	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dactinomycin—testicular cancer	0.000509	0.00331	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000507	0.0033	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Chlorambucil—testicular cancer	0.000506	0.00329	CcSEcCtD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KIT—testicular cancer	0.000505	0.00613	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Vinblastine—testicular cancer	0.000499	0.00325	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Methotrexate—testicular cancer	0.000499	0.00325	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—KITLG—testicular cancer	0.000498	0.00605	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Bleomycin—testicular cancer	0.000498	0.00324	CcSEcCtD
Aminosalicylic Acid—CHUK—PI-3K cascade—FGFR3—testicular cancer	0.000496	0.00602	CbGpPWpGaD
Aminosalicylic Acid—Vascular purpura—Epirubicin—testicular cancer	0.000493	0.00321	CcSEcCtD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000486	0.0059	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—FGFR3—testicular cancer	0.000484	0.00587	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—FGFR3—testicular cancer	0.00048	0.00583	CbGpPWpGaD
Aminosalicylic Acid—Nervous system disorder—Ifosfamide—testicular cancer	0.00048	0.00312	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Ifosfamide—testicular cancer	0.000479	0.00312	CcSEcCtD
Aminosalicylic Acid—Anaemia—Cisplatin—testicular cancer	0.000478	0.00311	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.000477	0.00579	CbGpPWpGaD
Aminosalicylic Acid—Skin disorder—Ifosfamide—testicular cancer	0.000475	0.00309	CcSEcCtD
Aminosalicylic Acid—PLA2G2E—Metabolism—HPGDS—testicular cancer	0.000475	0.00576	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Biological oxidations—HPGDS—testicular cancer	0.000472	0.00573	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Chlorambucil—testicular cancer	0.00047	0.00306	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—KITLG—testicular cancer	0.000469	0.0057	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—testicular cancer	0.000469	0.00569	CbGpPWpGaD
Aminosalicylic Acid—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000467	0.00304	CcSEcCtD
Aminosalicylic Acid—Anorexia—Ifosfamide—testicular cancer	0.000466	0.00303	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dactinomycin—testicular cancer	0.000464	0.00302	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vinblastine—testicular cancer	0.000464	0.00302	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Etoposide—testicular cancer	0.000464	0.00302	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Cisplatin—testicular cancer	0.000463	0.00301	CcSEcCtD
Aminosalicylic Acid—Purpura—Epirubicin—testicular cancer	0.000457	0.00297	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Doxorubicin—testicular cancer	0.000456	0.00297	CcSEcCtD
Aminosalicylic Acid—CHUK—PI-3K cascade—KIT—testicular cancer	0.000455	0.00552	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Bleomycin—testicular cancer	0.000455	0.00296	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Bleomycin—testicular cancer	0.000453	0.00294	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Epirubicin—testicular cancer	0.000452	0.00294	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vinblastine—testicular cancer	0.000448	0.00292	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signal transduction—KITLG—testicular cancer	0.000448	0.00544	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	0.000447	0.00542	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—KITLG—testicular cancer	0.000446	0.00541	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—KIT—testicular cancer	0.000444	0.00539	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—KITLG—testicular cancer	0.000444	0.00539	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—KITLG—testicular cancer	0.000442	0.00536	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000441	0.00287	CcSEcCtD
Aminosalicylic Acid—CHUK—GAB1 signalosome—KIT—testicular cancer	0.000441	0.00535	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Chlorambucil—testicular cancer	0.000439	0.00286	CcSEcCtD
Aminosalicylic Acid—Anaemia—Etoposide—testicular cancer	0.000438	0.00285	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000437	0.00284	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000437	0.00284	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.000435	0.00528	CbGpPWpGaD
Aminosalicylic Acid—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000432	0.00281	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vinblastine—testicular cancer	0.000431	0.0028	CcSEcCtD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—testicular cancer	0.000431	0.00523	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Ifosfamide—testicular cancer	0.000425	0.00277	CcSEcCtD
Aminosalicylic Acid—Headache—Vinblastine—testicular cancer	0.000425	0.00276	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Etoposide—testicular cancer	0.000424	0.00276	CcSEcCtD
Aminosalicylic Acid—Purpura—Doxorubicin—testicular cancer	0.000423	0.00275	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000423	0.00513	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000422	0.00275	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dactinomycin—testicular cancer	0.000422	0.00275	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dactinomycin—testicular cancer	0.000422	0.00275	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Bleomycin—testicular cancer	0.000422	0.00274	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Doxorubicin—testicular cancer	0.000418	0.00272	CcSEcCtD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000418	0.00507	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—KITLG—testicular cancer	0.000415	0.00504	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000415	0.00504	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—KITLG—testicular cancer	0.000415	0.00504	CbGpPWpGaD
Aminosalicylic Acid—Nervous system disorder—Cisplatin—testicular cancer	0.000414	0.00269	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Cisplatin—testicular cancer	0.000413	0.00269	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by EGFR—KITLG—testicular cancer	0.000412	0.005	CbGpPWpGaD
Aminosalicylic Acid—Skin disorder—Cisplatin—testicular cancer	0.00041	0.00267	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000408	0.00495	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000408	0.00265	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by PDGF—KITLG—testicular cancer	0.000406	0.00493	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Vinblastine—testicular cancer	0.000403	0.00262	CcSEcCtD
Aminosalicylic Acid—Anorexia—Cisplatin—testicular cancer	0.000402	0.00262	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.0004	0.0026	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Ifosfamide—testicular cancer	0.0004	0.0026	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Dactinomycin—testicular cancer	0.000393	0.00256	CcSEcCtD
Aminosalicylic Acid—Urticaria—Ifosfamide—testicular cancer	0.000389	0.00253	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Ifosfamide—testicular cancer	0.000387	0.00252	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Ifosfamide—testicular cancer	0.000387	0.00252	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Activation—KITLG—testicular cancer	0.000385	0.00467	CbGpPWpGaD
Aminosalicylic Acid—Abdominal distension—Epirubicin—testicular cancer	0.000384	0.00249	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Etoposide—testicular cancer	0.000378	0.00246	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Etoposide—testicular cancer	0.000375	0.00244	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—FGFR3—testicular cancer	0.00037	0.0045	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Etoposide—testicular cancer	0.000368	0.0024	CcSEcCtD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000368	0.00447	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Cisplatin—testicular cancer	0.000367	0.00239	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dactinomycin—testicular cancer	0.000365	0.00238	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000364	0.00237	CcSEcCtD
Aminosalicylic Acid—Vomiting—Bleomycin—testicular cancer	0.000364	0.00237	CcSEcCtD
Aminosalicylic Acid—Rash—Bleomycin—testicular cancer	0.000361	0.00235	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Bleomycin—testicular cancer	0.000361	0.00235	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Ifosfamide—testicular cancer	0.000361	0.00235	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Doxorubicin—testicular cancer	0.000355	0.00231	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000354	0.0043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—FGFR3—testicular cancer	0.000349	0.00423	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—STK11—testicular cancer	0.000345	0.00419	CbGpPWpGaD
Aminosalicylic Acid—Weight decreased—Epirubicin—testicular cancer	0.000345	0.00224	CcSEcCtD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000344	0.00418	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Bleomycin—testicular cancer	0.00034	0.00221	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—KIT—testicular cancer	0.00034	0.00413	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Dactinomycin—testicular cancer	0.00034	0.00221	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—testicular cancer	0.000339	0.0022	CcSEcCtD
Aminosalicylic Acid—Rash—Dactinomycin—testicular cancer	0.000337	0.00219	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Etoposide—testicular cancer	0.000336	0.00219	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Ifosfamide—testicular cancer	0.000335	0.00218	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Etoposide—testicular cancer	0.000334	0.00217	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Cisplatin—testicular cancer	0.000333	0.00217	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signal transduction—FGFR3—testicular cancer	0.000333	0.00404	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Epirubicin—testicular cancer	0.000333	0.00217	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by FGFR—FGFR3—testicular cancer	0.000331	0.00402	CbGpPWpGaD
Aminosalicylic Acid—Jaundice—Epirubicin—testicular cancer	0.000331	0.00215	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—FGFR3—testicular cancer	0.00033	0.004	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—FGFR3—testicular cancer	0.000328	0.00398	CbGpPWpGaD
Aminosalicylic Acid—Hepatitis—Methotrexate—testicular cancer	0.000326	0.00212	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000325	0.00395	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Ifosfamide—testicular cancer	0.000324	0.0021	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000323	0.00393	CbGpPWpGaD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—testicular cancer	0.000322	0.00209	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—KIT—testicular cancer	0.00032	0.00389	CbGpPWpGaD
Aminosalicylic Acid—Urethral disorder—Methotrexate—testicular cancer	0.000319	0.00208	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Doxorubicin—testicular cancer	0.000319	0.00207	CcSEcCtD
Aminosalicylic Acid—Nausea—Dactinomycin—testicular cancer	0.000317	0.00206	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Epirubicin—testicular cancer	0.000317	0.00206	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Etoposide—testicular cancer	0.000316	0.00206	CcSEcCtD
Aminosalicylic Acid—Vomiting—Ifosfamide—testicular cancer	0.000311	0.00202	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Cisplatin—testicular cancer	0.000311	0.00202	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000309	0.00375	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000309	0.00375	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—FGFR3—testicular cancer	0.000309	0.00375	CbGpPWpGaD
Aminosalicylic Acid—Rash—Ifosfamide—testicular cancer	0.000309	0.00201	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Ifosfamide—testicular cancer	0.000308	0.00201	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000308	0.002	CcSEcCtD
Aminosalicylic Acid—Urticaria—Etoposide—testicular cancer	0.000307	0.002	CcSEcCtD
Aminosalicylic Acid—Jaundice—Doxorubicin—testicular cancer	0.000306	0.00199	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by EGFR—FGFR3—testicular cancer	0.000306	0.00372	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—KIT—testicular cancer	0.000306	0.00371	CbGpPWpGaD
Aminosalicylic Acid—Body temperature increased—Etoposide—testicular cancer	0.000306	0.00199	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Etoposide—testicular cancer	0.000306	0.00199	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Epirubicin—testicular cancer	0.000305	0.00198	CcSEcCtD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	0.000305	0.0037	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—KIT—testicular cancer	0.000304	0.00369	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000303	0.00368	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—KIT—testicular cancer	0.000303	0.00368	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—FGFR3—testicular cancer	0.000302	0.00367	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—KIT—testicular cancer	0.000301	0.00366	CbGpPWpGaD
Aminosalicylic Acid—Urinary tract disorder—Epirubicin—testicular cancer	0.000301	0.00196	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Epirubicin—testicular cancer	0.000299	0.00194	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000297	0.00361	CbGpPWpGaD
Aminosalicylic Acid—Agranulocytosis—Doxorubicin—testicular cancer	0.000293	0.00191	CcSEcCtD
Aminosalicylic Acid—Nausea—Ifosfamide—testicular cancer	0.000291	0.00189	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Cisplatin—testicular cancer	0.000289	0.00188	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Activation—FGFR3—testicular cancer	0.000286	0.00347	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Etoposide—testicular cancer	0.000285	0.00185	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—testicular cancer	0.000284	0.00185	CcSEcCtD
Aminosalicylic Acid—CHUK—DAP12 interactions—KIT—testicular cancer	0.000284	0.00344	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—KIT—testicular cancer	0.000284	0.00344	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000284	0.00344	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KITLG—testicular cancer	0.000283	0.00344	CbGpPWpGaD
Aminosalicylic Acid—Hepatitis—Doxorubicin—testicular cancer	0.000282	0.00184	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by EGFR—KIT—testicular cancer	0.000281	0.00341	CbGpPWpGaD
Aminosalicylic Acid—Urinary tract disorder—Doxorubicin—testicular cancer	0.000279	0.00181	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000278	0.00338	CbGpPWpGaD
Aminosalicylic Acid—Dysgeusia—Methotrexate—testicular cancer	0.000278	0.00181	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by PDGF—KIT—testicular cancer	0.000277	0.00337	CbGpPWpGaD
Aminosalicylic Acid—Urethral disorder—Doxorubicin—testicular cancer	0.000277	0.0018	CcSEcCtD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000273	0.00332	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Cisplatin—testicular cancer	0.000268	0.00174	CcSEcCtD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL10—testicular cancer	0.000268	0.00325	CbGpPWpGaD
Aminosalicylic Acid—Rash—Cisplatin—testicular cancer	0.000266	0.00173	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Cisplatin—testicular cancer	0.000266	0.00173	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Epirubicin—testicular cancer	0.000265	0.00173	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Etoposide—testicular cancer	0.000264	0.00172	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Activation—KIT—testicular cancer	0.000262	0.00319	CbGpPWpGaD
Aminosalicylic Acid—Anaemia—Methotrexate—testicular cancer	0.000262	0.00171	CcSEcCtD
Aminosalicylic Acid—Flatulence—Epirubicin—testicular cancer	0.000262	0.0017	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Epirubicin—testicular cancer	0.00026	0.00169	CcSEcCtD
Aminosalicylic Acid—CHUK—Adaptive Immune System—BCL10—testicular cancer	0.000257	0.00312	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Etoposide—testicular cancer	0.000256	0.00166	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—testicular cancer	0.000254	0.00165	CcSEcCtD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000251	0.00305	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Cisplatin—testicular cancer	0.000251	0.00163	CcSEcCtD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.00025	0.00304	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Etoposide—testicular cancer	0.000246	0.0016	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Doxorubicin—testicular cancer	0.000246	0.0016	CcSEcCtD
Aminosalicylic Acid—Anaemia—Epirubicin—testicular cancer	0.000245	0.0016	CcSEcCtD
Aminosalicylic Acid—Rash—Etoposide—testicular cancer	0.000244	0.00159	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Etoposide—testicular cancer	0.000243	0.00158	CcSEcCtD
Aminosalicylic Acid—Headache—Etoposide—testicular cancer	0.000242	0.00157	CcSEcCtD
Aminosalicylic Acid—Flatulence—Doxorubicin—testicular cancer	0.000242	0.00157	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Doxorubicin—testicular cancer	0.000241	0.00156	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00024	0.00156	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Epirubicin—testicular cancer	0.000238	0.00155	CcSEcCtD
Aminosalicylic Acid—Nausea—Etoposide—testicular cancer	0.00023	0.00149	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—testicular cancer	0.000227	0.00148	CcSEcCtD
Aminosalicylic Acid—Anaemia—Doxorubicin—testicular cancer	0.000227	0.00148	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—testicular cancer	0.000227	0.00147	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—testicular cancer	0.000225	0.00146	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000224	0.00146	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—testicular cancer	0.000221	0.00144	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Doxorubicin—testicular cancer	0.00022	0.00143	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Epirubicin—testicular cancer	0.000212	0.00138	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Epirubicin—testicular cancer	0.000212	0.00138	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Epirubicin—testicular cancer	0.00021	0.00137	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGFR3—testicular cancer	0.00021	0.00255	CbGpPWpGaD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000208	0.00135	CcSEcCtD
Aminosalicylic Acid—Anorexia—Epirubicin—testicular cancer	0.000207	0.00134	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling Pathways—INSL3—testicular cancer	0.000206	0.00251	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Methotrexate—testicular cancer	0.000201	0.00131	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—testicular cancer	0.0002	0.0013	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Doxorubicin—testicular cancer	0.000197	0.00128	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Doxorubicin—testicular cancer	0.000196	0.00128	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Doxorubicin—testicular cancer	0.000195	0.00127	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by NGF—KIT—testicular cancer	0.000193	0.00234	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Doxorubicin—testicular cancer	0.000191	0.00124	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—testicular cancer	0.000189	0.00123	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Epirubicin—testicular cancer	0.000188	0.00122	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000187	0.00122	CcSEcCtD
Aminosalicylic Acid—ALOX5—Metabolism—HPGDS—testicular cancer	0.000186	0.00226	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Methotrexate—testicular cancer	0.000184	0.0012	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—testicular cancer	0.000183	0.00119	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—testicular cancer	0.000183	0.00119	CcSEcCtD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000181	0.0022	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Epirubicin—testicular cancer	0.000177	0.00115	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Doxorubicin—testicular cancer	0.000174	0.00113	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000173	0.00113	CcSEcCtD
Aminosalicylic Acid—Urticaria—Epirubicin—testicular cancer	0.000172	0.00112	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Epirubicin—testicular cancer	0.000171	0.00111	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Epirubicin—testicular cancer	0.000171	0.00111	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—testicular cancer	0.000171	0.00111	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000164	0.00107	CcSEcCtD
Aminosalicylic Acid—CHUK—Innate Immune System—KITLG—testicular cancer	0.000161	0.00196	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Epirubicin—testicular cancer	0.00016	0.00104	CcSEcCtD
Aminosalicylic Acid—Urticaria—Doxorubicin—testicular cancer	0.000159	0.00104	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Doxorubicin—testicular cancer	0.000158	0.00103	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Doxorubicin—testicular cancer	0.000158	0.00103	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methotrexate—testicular cancer	0.000158	0.00103	CcSEcCtD
Aminosalicylic Acid—CHUK—Immune System—BCL10—testicular cancer	0.000156	0.00189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KITLG—testicular cancer	0.000155	0.00188	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Methotrexate—testicular cancer	0.000153	0.000996	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Epirubicin—testicular cancer	0.000148	0.000964	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Doxorubicin—testicular cancer	0.000148	0.000961	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methotrexate—testicular cancer	0.000147	0.000957	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—testicular cancer	0.000146	0.000949	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—testicular cancer	0.000146	0.000949	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—testicular cancer	0.000145	0.000943	CcSEcCtD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000144	0.00175	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Epirubicin—testicular cancer	0.000143	0.000932	CcSEcCtD
Aminosalicylic Acid—Vomiting—Epirubicin—testicular cancer	0.000138	0.000896	CcSEcCtD
Aminosalicylic Acid—Nausea—Methotrexate—testicular cancer	0.000138	0.000894	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Doxorubicin—testicular cancer	0.000137	0.000892	CcSEcCtD
Aminosalicylic Acid—Rash—Epirubicin—testicular cancer	0.000137	0.000889	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Epirubicin—testicular cancer	0.000136	0.000888	CcSEcCtD
Aminosalicylic Acid—Headache—Epirubicin—testicular cancer	0.000136	0.000883	CcSEcCtD
Aminosalicylic Acid—ALOX5—Metabolism—STK11—testicular cancer	0.000135	0.00164	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Doxorubicin—testicular cancer	0.000133	0.000862	CcSEcCtD
Aminosalicylic Acid—Nausea—Epirubicin—testicular cancer	0.000129	0.000837	CcSEcCtD
Aminosalicylic Acid—Vomiting—Doxorubicin—testicular cancer	0.000127	0.000829	CcSEcCtD
Aminosalicylic Acid—Rash—Doxorubicin—testicular cancer	0.000126	0.000822	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Doxorubicin—testicular cancer	0.000126	0.000821	CcSEcCtD
Aminosalicylic Acid—Headache—Doxorubicin—testicular cancer	0.000126	0.000817	CcSEcCtD
Aminosalicylic Acid—CHUK—Innate Immune System—FGFR3—testicular cancer	0.00012	0.00146	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Doxorubicin—testicular cancer	0.000119	0.000774	CcSEcCtD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGFR3—testicular cancer	0.000115	0.0014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KIT—testicular cancer	0.00011	0.00134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KIT—testicular cancer	0.000106	0.00128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—H2AFZ—testicular cancer	9.44e-05	0.00115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KITLG—testicular cancer	9.4e-05	0.00114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KITLG—testicular cancer	8.68e-05	0.00105	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HPGDS—testicular cancer	8.07e-05	0.00098	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGFR3—testicular cancer	6.99e-05	0.000848	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—H2AFZ—testicular cancer	6.61e-05	0.000802	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STK11—testicular cancer	6.57e-05	0.000798	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGFR3—testicular cancer	6.45e-05	0.000783	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KIT—testicular cancer	6.42e-05	0.000779	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HPGDS—testicular cancer	6.41e-05	0.000778	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KITLG—testicular cancer	6.08e-05	0.000738	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KIT—testicular cancer	5.92e-05	0.000719	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—STK11—testicular cancer	5.86e-05	0.000712	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—H2AFZ—testicular cancer	5.59e-05	0.000679	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KITLG—testicular cancer	5.14e-05	0.000624	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—STK11—testicular cancer	4.65e-05	0.000565	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR3—testicular cancer	4.52e-05	0.000548	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KIT—testicular cancer	4.15e-05	0.000504	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR3—testicular cancer	3.82e-05	0.000464	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KIT—testicular cancer	3.51e-05	0.000426	CbGpPWpGaD
